HoLEP、PKRP治疗良性前列腺增生症临床效果比较
发布时间:2018-12-12 05:59
【摘要】:目的比较经尿道钬激光前列腺剜除术(HoLEP)、等离子前列腺电切术(PKRP)治疗良性前列腺增生症(BPH)的临床效果。方法 BPH患者202例,其中行HoLEP者115例、行PKRP者87例,比较两组临床效果。结果与PKRP组比较,HoLEP组手术时间、膀胱冲洗时间、留置尿管时间、住院时间均缩短,血红蛋白下降幅度小,切除标本重量大(P均0.05)。与PKRP组比较,HoLEP组T1国际前列腺症状评分(IPSS)、残余尿(PVR)改善幅度明显,T2IPSS、生活质量评分、最大尿流率、PVR改善明显(P均0.05)。与PKRP组比较,HoLEP组围术期总并发症较低(P0.05)。结论 HoLEP、PKRP治疗BPH均可取得良好疗效,且较为安全;但HoLEP较PKRP可减少手术时间、膀胱冲洗时间、留置尿管时间、住院时间,提高患者生活质量,且总并发症发生率减少。
[Abstract]:Objective to compare the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP),) plasma prostatectomy (PKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods 202 patients with BPH were treated with HoLEP (115 cases) and 87 cases with PKRP (87 cases). Results compared with PKRP group, the operation time, bladder irrigation time, indwelling time and hospitalization time of HoLEP group were all shortened, hemoglobin decreased slightly, and the weight of excision specimen was larger (P 0.05). Compared with PKRP group, T1 international prostatic symptom score of HoLEP group showed significant improvement in (PVR) residual urine, T2IPSS, quality of life score, maximum flow rate and PVR improved significantly (all P 0.05). Compared with PKRP group, the total perioperative complications in HoLEP group were lower (P0.05). Conclusion HoLEP,PKRP is safe and effective in the treatment of BPH, but HoLEP can reduce the operation time, bladder irrigation time, indwelling urinary catheter time, hospitalization time, improve the quality of life of patients, and reduce the incidence of total complications.
【作者单位】: 三峡大学第一临床医学院;三峡大学泌尿外科研究所;
【分类号】:R699.8
,
本文编号:2374050
[Abstract]:Objective to compare the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP),) plasma prostatectomy (PKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods 202 patients with BPH were treated with HoLEP (115 cases) and 87 cases with PKRP (87 cases). Results compared with PKRP group, the operation time, bladder irrigation time, indwelling time and hospitalization time of HoLEP group were all shortened, hemoglobin decreased slightly, and the weight of excision specimen was larger (P 0.05). Compared with PKRP group, T1 international prostatic symptom score of HoLEP group showed significant improvement in (PVR) residual urine, T2IPSS, quality of life score, maximum flow rate and PVR improved significantly (all P 0.05). Compared with PKRP group, the total perioperative complications in HoLEP group were lower (P0.05). Conclusion HoLEP,PKRP is safe and effective in the treatment of BPH, but HoLEP can reduce the operation time, bladder irrigation time, indwelling urinary catheter time, hospitalization time, improve the quality of life of patients, and reduce the incidence of total complications.
【作者单位】: 三峡大学第一临床医学院;三峡大学泌尿外科研究所;
【分类号】:R699.8
,
本文编号:2374050
本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2374050.html
最近更新
教材专著